Dolor rhoncus vel morbi tristique tempor nulla ac semper felis aliquet vel. Praesent consectetur risus luctus.

Augue lectus varius elit nec bibendum mipsum ut est. Aenean consectetur fringilla felis condimentum pharetra.

Augue lectus varius elit nec bibendum mipsum ut est. Aenean consectetur fringilla felis condimentum pharetra.

Sagittis semper donec lacinia enim non orci pretium accumsan. Vestibulum rhoncus ante idal rutrum posuere.

Synedica Somatotropin is a high-quality synthetic recombinant form of human growth hormone (HGH).

HGH stimulates muscle hypertrophy, improves recovery times, and aids in fat metabolism.

This product comes in a 200iu kit, consisting of 20 x 10iu vials and 2 x 10ml vial of bacteriostatic water.

Designed for subcutaneous injection, Synedica Somatotropin is the safest and most convenient way to supplement HGH.

Dosage advice is to start with 1-2iu per day, gradually increasing the dosage. Consulting with a healthcare professional is advised to determine the optimal dosage for your specific needs.

⚠️ Important Notice

All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.

🔬 Suitable R&D Applications

🧪 Stability Testing

• Thermal, enzymatic, and oxidative degradation studies

• Shelf-life evaluation & formulation robustness

⚗️ Formulation Development

• Enhances solubility, bioavailability, and structural integrity

• Tailored for injectable, topical, and research-grade use

🧩 Excipient Compatibility Testing

• Evaluates interactions between peptides & inactive components

• Ensures safety, stability, and performance

🔒 Protease Resistance Evaluation

• Assesses susceptibility to enzymatic breakdown

• Supports development of more durable peptide products

📦 Encapsulation & Carrier Systems

• Liposomes, microspheres, and other delivery vehicles

• Protects peptides & enables controlled release

💉 Administration Route Assessment

Optimized for:

• Parenteral delivery (injectables)

• Dermal absorption (cosmetic/topical)

• In vitro research applications

Metus ac odio consectetur viverra. Aliquet ultrices dui eget tristique arcu finibus eu. Baecenas posuere odio.

Synedica Semaglutide® Injection Pen Kit is the world’s most advanced weight loss solution. Commonly known as “Ozempic,” semaglutide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of GLP-1, a natural hormone that makes humans feel full from eating much smaller portions of food.

The Synedica Semaglutide® 1mg Injection Pen Kit contains 2 pens, 12 disposable needles and an instruction booklet.

Each pen has 4mg which can be delivered across 4 full doses of 1mg, or in increments of 0.25mg, 0.5mg, 0.75mg or 1mg.

Recommended dosage is 0.25mg for the first 4 weeks, then 0.5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 0.75mg or 1mg.

⚠️ Important Notice

All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.

🔬 Suitable R&D Applications

🧪 Stability Testing

• Thermal, enzymatic, and oxidative degradation studies

• Shelf-life evaluation & formulation robustness

⚗️ Formulation Development

• Enhances solubility, bioavailability, and structural integrity

• Tailored for injectable, topical, and research-grade use

🧩 Excipient Compatibility Testing

• Evaluates interactions between peptides & inactive components

• Ensures safety, stability, and performance

🔒 Protease Resistance Evaluation

• Assesses susceptibility to enzymatic breakdown

• Supports development of more durable peptide products

📦 Encapsulation & Carrier Systems

• Liposomes, microspheres, and other delivery vehicles

• Protects peptides & enables controlled release

💉 Administration Route Assessment

Optimized for:

• Parenteral delivery (injectables)

• Dermal absorption (cosmetic/topical)

• In vitro research applications

Metus ac odio consectetur viverra. Aliquet ultrices dui eget tristique arcu finibus eu. Baecenas posuere odio.

Synedica Retatrutide® Injection Pen Kit is the world’s most advanced weight loss solution. Retatrutide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of the GLP-1, GIP and glucagon receptors, which are natural hormones that makes humans feel full from eating much smaller portions of food.

The Synedica Retatrutide® 40mg Injection Pen Kit contains 1 pen, 12 disposable needles and an instruction booklet.

Each pen has 40mg which can be delivered across 4 full doses of 10mg, or in increments of 2.5mg, 5mg, 7.5mg or 10mg.

Recommended dosage is 2.5mg for the first 4 weeks, then 5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 7.5mg or 10mg if necessary.

⚠️ Important Notice

All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.

🔬 Suitable R&D Applications

🧪 Stability Testing

• Thermal, enzymatic, and oxidative degradation studies

• Shelf-life evaluation & formulation robustness

⚗️ Formulation Development

• Enhances solubility, bioavailability, and structural integrity

• Tailored for injectable, topical, and research-grade use

🧩 Excipient Compatibility Testing

• Evaluates interactions between peptides & inactive components

• Ensures safety, stability, and performance

🔒 Protease Resistance Evaluation

• Assesses susceptibility to enzymatic breakdown

• Supports development of more durable peptide products

📦 Encapsulation & Carrier Systems

• Liposomes, microspheres, and other delivery vehicles

• Protects peptides & enables controlled release

💉 Administration Route Assessment

Optimized for:

• Parenteral delivery (injectables)

• Dermal absorption (cosmetic/topical)

• In vitro research applications

Augue lectus varius elit nec bibendum mipsum ut est. Aenean consectetur fringilla felis condimentum pharetra.

Metus ac odio consectetur viverra. Aliquet ultrices dui eget tristique arcu finibus eu. Baecenas posuere odio.

Augue lectus varius elit nec bibendum mipsum ut est. Aenean consectetur fringilla felis condimentum pharetra.